Aescap

Home
Funds
Biotech
About us
Invest
Cure-Finder
Contact
- Information meetings
Login

Fund structure

Fund structure09.17.2021

Aescap Life Sciences Fund
Aescap Genetics Fund
Performance
Sustainability

Attend our meetings

News

Aescap funds >10% up in 1 day October 17, 2024
Uniqure 76% up on significant improvement in Huntington disease July 10, 2024
Aescap’s Calliditas Therapeutics received a takeover bid from Asahi Kasei: 83% premium May 28, 2024

Aescap
Arent Janszoon Ernststraat 595C, 2nd floor, 1082 LD Amsterdam, Nederland
Tel. + 31 20 570 29 40 E-mail: service@aescap.com
Alle rechten voorbehouden. © 2023
Privacy Statement

This is marketing communication.Do not run any unnecessary risk. Read the Key Information Document of the Funds. This communication is neither an offer to sell nor a solicitation to invest. Past performance is not indicative of future results. The value of investments and any income generated may go down as well as up and is not guaranteed. Privium Fund Management B.V. (Privium) is authorized and regulated by the Dutch Authority for the Financial Markets (www.afm.nl) as an Alternative Investment Fund Manager (AIFM). The Funds and its manager, Privium Fund Management B.V., are held in the register of Dutch Authority for the Financial Markets. The Prospectus of the Funds and the Key Information Documents can be downloaded via the website of the Funds (www.aescap.com) and the Fund Manager (www.priviumfund.com). The performance overviews shown in this communication have been carefully composed by Privium Fund Management B.V. No rights can be derived from this communication.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.